Tuesday, February 18, 2020

 


Hexo Corp
(TSX: HEXO.TO) Add to Watchlist
$2.00
+0.32 (+19.05%)
as of Feb 14, 2020

TORONTO — Some of the most active companies traded Friday on the Toronto Stock Exchange:  (full story)
BBD-B.TO: 1.65 (-0.02), ACB.TO: 2.06 (+0.10), ENB.TO: 56.03 (+0.28), HEXO.TO: 2.00 (+0.32), ABX.TO: 26.12 (+1.00), BTE.TO: 1.45 (-0.02), MTY.TO: 54.68 (-5.05)
Recent industry reports show that the recreational cannabis beverage industry is on the rise, and nanoemulsion-infused beverages are leading to the development of drinkable cannabis products that are both potent and fast acting. Transparency Market Research (TMR) is predicting an increased growth in  (full story)
PBIO: 2.5000 (-0.0200), APHA: 4.31 (+0.15), APHA.TO: 5.70 (+0.22), HEXO: 1.52 (+0.25), HEXO.TO: 2.00 (+0.32), CGC: 22.13 (+2.61), WEED.TO: 29.98 (+4.10)
CBD. Those three little letters led to a banner year of beauty and wellness product launches, retail partnerships and big-money acquisitions. The non-psychoactive cannabinoid known for its ability to fight everything from inflammation to insomnia is still ascending. CBD's impact on the consumer pack  (full story)
POTND: 0.0200 (+0.0049), PG: 126.14 (+1.18), MCOA: 0.0396 (+0.0031), POTN: 0.0257 (-0.0011), HEXO: 1.52 (+0.25), HEXO.TO: 2.00 (+0.32), OGI: 2.72 (+0.32)
OTTAWA — Shares in cannabis firm Hexo Corp. tumbled Friday by as much as 21 per cent on the Toronto Stock Exchange after it announced it would issue about 15 million new shares, a move that could dilute the value of its existing stock.  (full story)
HEXO.TO: 2.00 (+0.32)
Ever since "Legalization 2.0" was first announced, investors have been looking to it as a fulfillment of the long-promised pot gold rush. As of December 17, consumable pot products can be bought and sold on shelves across Canada and, as such, the industry is undergoing a significant disruption. Acc  (full story)
WEED.TO: 29.98 (+4.10), CGC: 22.13 (+2.61), CRON.TO: 9.69 (+0.57), CRON: 7.34 (+0.47), ACB.TO: 2.06 (+0.10), ACB: 1.58 (+0.11)
OTTAWA — Cannabis company Hexo Corp. says it lost $62.4 million in its latest quarter compared with a loss of $12.8 million in the same quarter last year.  (full story)
HEXO.TO: 2.00 (+0.32)
For the second year, the U.S. FDA designated psilocybin, a compound found in hallucinogenic mushrooms, as a "breakthrough therapy" for the treatment of major depressive disorder (MDD). "This designation, which is designed to expedite the development and review of drugs--given out only for therapies  (full story)
BOSS.CN: 0.260 (+0.005), BOSQF: 0.1994 (+0.0038), HEXO: 1.52 (+0.25), HEXO.TO: 2.00 (+0.32), TRUL.CN: 14.140 (+0.540), TCNNF: 10.6700 (+0.4200), TGOD.TO: 0.57 (-0.02)
Many more Americans now support cannabis legalization. A Pew Research Center survey now finds that 67% are in support. That's up from 62% year. Better, the House Judiciary Committee just passed The Marijuana Opportunity Reinvestment and Expungement (MORE) Act with a vote of 24 to 10. While the bill  (full story)
EAT.CN: 0.035 (unch), SPLIF: 0.0282 (-0.0005), APHA: 4.31 (+0.15), APHA.TO: 5.70 (+0.22), TLRY: 17.39 (+1.26), HEXO: 1.52 (+0.25)
© 2020 Market data provided and hosted by Barchart Market Data Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.